The suits, added Tuesday to the consolidated class action suit currently pending in the U.S. District Court for the Southern District of New York, were originally filed in Delaware by Purdue Pharma. In the suits, the drug maker accuses generic pharmaceutical company KV Pharmaceuticals Inc. of infringing three patents for Oxycontin.